Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 1989-10-01 (36 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINTE-MARIE-DE-RE (17740), Charente-Maritime
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE SAINTE MARIE : revenue, balance sheet and financial ratios
PHARMACIE DE SAINTE MARIE is a French company
founded 36 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINTE-MARIE-DE-RE (17740),
this company of category PME
shows in 2022 a revenue of 2.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE SAINTE MARIE (SIREN 352845358)
Indicator
2023
2022
2020
2019
2018
2017
2016
Revenue
N/C
2 413 070 €
N/C
N/C
N/C
N/C
N/C
Net income
111 110 €
138 615 €
79 357 €
320 979 €
188 791 €
-248 979 €
60 472 €
EBITDA
N/C
204 668 €
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
5.7%
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE DE SAINTE MARIE generates positive net income of 111 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2023: 60 k€ -> 111 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
111 110 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 49%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 62%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
49.433%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
61.973%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE SAINTE MARIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
Debt ratio
130.876
170.894
115.512
68.147
62.55
51.232
49.433
Financial autonomy
37.525
31.768
40.582
51.765
55.623
61.225
61.973
Repayment capacity
None
None
None
None
None
4.641
None
Cash flow / Revenue
None%
None%
None%
None%
None%
5.998%
None%
Sector positioning
Debt ratio
49.432023
2020
2022
2023
Q1: 20.09
Med: 66.92
Q3: 169.24
Good
In 2023, the debt ratio of PHARMACIE DE SAINTE MARIE (49.43) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
61.97%2023
2020
2022
2023
Q1: 28.72%
Med: 48.51%
Q3: 68.17%
Good
In 2023, the financial autonomy of PHARMACIE DE SAINTE MARIE (62.0%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
4.64 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE DE SAINTE MARIE (4.64) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 255.96. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
255.956
Liquidity indicators evolution PHARMACIE DE SAINTE MARIE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2022
2023
Liquidity ratio
148.174
182.587
187.883
163.128
221.555
315.893
255.956
Interest coverage
None
None
None
None
None
7.403
None
Sector positioning
Liquidity ratio
255.962023
2020
2022
2023
Q1: 135.23
Med: 189.76
Q3: 270.17
Good+6 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE DE SAINTE MARIE (255.96) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
7.4x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Excellent
In 2022, the interest coverage of PHARMACIE DE SAINTE MARIE (7.4x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2023)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2023)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2023)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2023)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE SAINTE MARIE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2022
2023
Operating WCR
0 €
0 €
0 €
0 €
0 €
276 683 €
0 €
Inventory turnover (days)
0
0
0
0
0
23
0
Customer payment term (days)
0
0
0
0
0
3
0
Supplier payment term (days)
0
0
0
0
0
15
0
Positioning of PHARMACIE DE SAINTE MARIE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 220 transactions of similar company sales
in 2023,
the value of PHARMACIE DE SAINTE MARIE is estimated at
1 311 039 €
(range 797 306€ - 1 843 027€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
220 transactions
797k€1311k€1843k€
1 311 039 €Range: 797 306€ - 1 843 027€
NAF 5 année 2023
Valuation method used
Net Income Multiple
111 110 €
×
11.8x
=1 311 040 €
Range: 797 306€ - 1 843 028€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 220 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE SAINTE MARIE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE SAINTE MARIE
What is the revenue of PHARMACIE DE SAINTE MARIE ?
The revenue of PHARMACIE DE SAINTE MARIE in 2022 is 2.4 M€.
Is PHARMACIE DE SAINTE MARIE profitable?
Yes, PHARMACIE DE SAINTE MARIE generated a net profit of 111 k€ in 2023.
Where is the headquarters of PHARMACIE DE SAINTE MARIE ?
The headquarters of PHARMACIE DE SAINTE MARIE is located in SAINTE-MARIE-DE-RE (17740), in the department Charente-Maritime.
Where to find the tax return of PHARMACIE DE SAINTE MARIE ?
The tax return of PHARMACIE DE SAINTE MARIE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE SAINTE MARIE operate?
PHARMACIE DE SAINTE MARIE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart